14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
MARS vs ORBX: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
MARS Wins Head-to-Head Institutional Verdict (0–0 across 6 Pillars · 1–2 Matrix Metrics)
MARS Overall Winner
6-Pillar Tally: MARS 0 – 0 ORBX (6 Tie)
Matrix Metrics: MARS 1 – 2 ORBX
As of Nov 16, 2026, MARS (MARS) is the stronger overall head-to-head candidate over ORBX (ORBX) in the Tradestie Institutional Equity Comparison Engine, winning 1–2 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). MARS carries a Unified Composite Score of 46.3/100 (HOLD) at $21.55 (N/M Forward P/E, N/A operating margin), whereas ORBX carries 48.2/100 (HOLD) at $35.28 (N/M Forward P/E, N/A operating margin).
Composite vs. Pillar Nuance: While ORBX currently prints a higher short-term Unified Composite Score (48.2/100 HOLD vs. MARS 46.3/100 HOLD), MARS captures the overall institutional head-to-head verdict (1–2 matrix metrics and 0–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY).
Technical & Structure Timing Caution: MARS is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 42.5); meanwhile ORBX is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 42.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MARS vs ORBX. Trailing 12-month operating profitability (MARS N/A vs ORBX N/A) and valuation multiples (MARS N/M vs ORBX N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ MARS vs ORBX Key Questions & Quantitative Answers
As of Nov 16, 2026, MARS (MARS) is the stronger overall head-to-head candidate over ORBX (ORBX) in the Tradestie Institutional Equity Comparison Engine, winning 1–2 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). MARS carries a Unified Composite Score of 46.3/100 (HOLD) at $21.55 (N/M Forward P/E, N/A operating margin), whereas ORBX carries 48.2/100 (HOLD) at $35.28 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While ORBX currently prints a higher short-term Unified Composite Score (48.2/100 HOLD vs. MARS 46.3/100 HOLD), MARS captures the overall institutional head-to-head verdict (1–2 matrix metrics and 0–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY). Technical & Structure Timing Caution: MARS is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 42.5); meanwhile ORBX is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 42.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
MARS and ORBX split Growth & Scale metrics: MARS posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with ORBX at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, MARS generates N/A in USD-normalized revenue versus N/A for ORBX. In operating R&D and SG&A reinvestment, MARS deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for ORBX.
MARS and ORBX trade at balanced relative valuation multiples. MARS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas ORBX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against MARS (N/A ROE) versus ORBX (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, MARS carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.55β · 70% Vol realized risk). By comparison, ORBX carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.76β · 70% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.